
    
      The duration of the study per participant was approximately 2 years. Each participant was
      treated until radiographic disease progression, unacceptable toxicity, or participants
      refusal of further study treatment, and each participant was followed after completion of
      study treatment until death, study cutoff date, or withdrawal of participant consent.
    
  